BRCA1 inhibitors (Onyx/Lilly)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameBRCA1 inhibitors (Onyx/Lilly)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionOncogene proteins inhibitors
TargetsOncogene proteins
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOnyx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesValentisEli Lilly And CompanyOnyx Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A